Baizean® (Tilelizumab) boasted four major advantages: a greater degree of permanent blockade of the Fab segment, a unique modification of the Fc segment, a long half-life, and strong anti-tumor activity.
The Benzean ® boasts four major advantages: a greater degree of long-lasting blocking in the Fab segment, a unique modification of the Fc segment, a long half-life, and strong anti-tumor activity.
Baizean (tirelizumab) boasts four advantages: more persistent blocking of Fab segment, unique modification of FC segment, long half-life and strong anti-tumor activity.